Lipocine Inc (LPCN): Hopefully the company is working with th...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Lipocine Inc (LPCN)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	0
Posts	161
Boards Moderated	0
Alias Born	03/31/2014

Re: None

Tuesday, 01/23/2018 10:25:04 AM

Tuesday, January 23, 2018 10:25:04 AM

Hopefully the company is working with the FDA to develop some studies to address ABP, CV and ex vivo T conversion issues presented by adcomm. May is still a long ways out. Best case scenario, other than FDA approval in May, is another slight 3-6 month PDUFA delay to ammend the NDA package with additional data. All IMO.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent LPCN News

Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154 • PR Newswire (US) • 05/01/2024 12:00:00 PM
Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity • PR Newswire (US) • 04/11/2024 11:00:00 AM
Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis • PR Newswire (US) • 03/28/2024 12:00:00 PM
Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154 • PR Newswire (US) • 03/25/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 10:31:06 PM
Lipocine Announces Financial Results for the Full Year Ended December 31, 2023 • PR Newswire (US) • 03/07/2024 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:08:06 AM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/07/2024 11:07:26 AM
Lipocine to Present at 36th Annual Roth Conference • PR Newswire (US) • 03/06/2024 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 11:01:31 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 09:10:26 PM
Lipocine Announces Confirmation of Dosing Regimen for Pivotal Study of LPCN 1154 • PR Newswire (US) • 02/06/2024 01:00:00 PM
Lipocine Announces Continued Commercialization of TLANDO® through Verity Pharmaceuticals • PR Newswire (US) • 02/02/2024 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 01:20:46 PM
Lipocine and Verity Pharma Enter into License Agreement for TLANDO® Franchise in the U.S. and Canada • PR Newswire (US) • 01/18/2024 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 03:00:12 PM
Lipocine to Present at Biotech Showcase 2024 • PR Newswire (US) • 12/19/2023 01:00:00 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/22/2023 09:15:57 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 07:45:33 PM
Lipocine Releases Late Breaking Presentation on LPCN 1148 Phase 2 Results at The Liver Meeting® 2023 • PR Newswire (US) • 11/13/2023 07:45:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 06:15:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 02:50:30 PM
Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2023 • PR Newswire (US) • 11/08/2023 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 01:31:11 PM
Lipocine to Present Clinical Data on LPCN 1148 at The Liver Meeting® 2023 • PR Newswire (US) • 11/01/2023 12:00:00 PM

More LPCN News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow